These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 25421323

  • 1. Delivery of berberine using chitosan/fucoidan-taurine conjugate nanoparticles for treatment of defective intestinal epithelial tight junction barrier.
    Wu SJ, Don TM, Lin CW, Mi FL.
    Mar Drugs; 2014 Nov 24; 12(11):5677-97. PubMed ID: 25421323
    [Abstract] [Full Text] [Related]

  • 2. Delivery of polysaccharides from Ophiopogon japonicus (OJPs) using OJPs/chitosan/whey protein co-assembled nanoparticles to treat defective intestinal epithelial tight junction barrier.
    Lin C, Kuo TC, Lin JC, Ho YC, Mi FL.
    Int J Biol Macromol; 2020 Oct 01; 160():558-570. PubMed ID: 32464213
    [Abstract] [Full Text] [Related]

  • 3. Soluble eggshell membrane protein-loaded chitosan/fucoidan nanoparticles for treatment of defective intestinal epithelial cells.
    Lee MC, Huang YC.
    Int J Biol Macromol; 2019 Jun 15; 131():949-958. PubMed ID: 30910672
    [Abstract] [Full Text] [Related]

  • 4. Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cells.
    Li N, Gu L, Qu L, Gong J, Li Q, Zhu W, Li J.
    Eur J Pharm Sci; 2010 Apr 16; 40(1):1-8. PubMed ID: 20149867
    [Abstract] [Full Text] [Related]

  • 5. Mutlifunctional nanoparticles prepared from arginine-modified chitosan and thiolated fucoidan for oral delivery of hydrophobic and hydrophilic drugs.
    Chen CH, Lin YS, Wu SJ, Mi FL.
    Carbohydr Polym; 2018 Aug 01; 193():163-172. PubMed ID: 29773368
    [Abstract] [Full Text] [Related]

  • 6. Development of mutlifunctional nanoparticles self-assembled from trimethyl chitosan and fucoidan for enhanced oral delivery of insulin.
    Tsai LC, Chen CH, Lin CW, Ho YC, Mi FL.
    Int J Biol Macromol; 2019 Apr 01; 126():141-150. PubMed ID: 30586591
    [Abstract] [Full Text] [Related]

  • 7. Nanoparticle-induced tight-junction opening for the transport of an anti-angiogenic sulfated polysaccharide across Caco-2 cell monolayers.
    Yu SH, Tang DW, Hsieh HY, Wu WS, Lin BX, Chuang EY, Sung HW, Mi FL.
    Acta Biomater; 2013 Jul 01; 9(7):7449-59. PubMed ID: 23583645
    [Abstract] [Full Text] [Related]

  • 8. FRET-based dual-emission and pH-responsive nanocarriers for enhanced delivery of protein across intestinal epithelial cell barrier.
    Lu KY, Lin CW, Hsu CH, Ho YC, Chuang EY, Sung HW, Mi FL.
    ACS Appl Mater Interfaces; 2014 Oct 22; 6(20):18275-89. PubMed ID: 25260022
    [Abstract] [Full Text] [Related]

  • 9. Preparation of fucoidan-shelled and genipin-crosslinked chitosan beads for antibacterial application.
    Yu SH, Wu SJ, Wu JY, Wen DY, Mi FL.
    Carbohydr Polym; 2015 Aug 01; 126():97-107. PubMed ID: 25933528
    [Abstract] [Full Text] [Related]

  • 10. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
    Sadeghi AM, Dorkoosh FA, Avadi MR, Weinhold M, Bayat A, Delie F, Gurny R, Larijani B, Rafiee-Tehrani M, Junginger HE.
    Eur J Pharm Biopharm; 2008 Sep 01; 70(1):270-8. PubMed ID: 18492606
    [Abstract] [Full Text] [Related]

  • 11. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
    Sandri G, Bonferoni MC, Rossi S, Ferrari F, Gibin S, Zambito Y, Di Colo G, Caramella C.
    Eur J Pharm Biopharm; 2007 Jan 01; 65(1):68-77. PubMed ID: 16962751
    [Abstract] [Full Text] [Related]

  • 12. Methylated N-(4-N,N-dimethylaminobenzyl) chitosan, a novel chitosan derivative, enhances paracellular permeability across intestinal epithelial cells (Caco-2).
    Kowapradit J, Opanasopit P, Ngawhiranpat T, Apirakaramwong A, Rojanarata T, Ruktanonchai U, Sajomsang W.
    AAPS PharmSciTech; 2008 Jan 01; 9(4):1143-52. PubMed ID: 19009354
    [Abstract] [Full Text] [Related]

  • 13. Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cells.
    Beutheu S, Ghouzali I, Galas L, Déchelotte P, Coëffier M.
    Clin Nutr; 2013 Oct 01; 32(5):863-9. PubMed ID: 23428392
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions.
    Qasim M, Rahman H, Ahmed R, Oellerich M, Asif AR.
    Exp Cell Res; 2014 Apr 01; 322(2):277-89. PubMed ID: 24509232
    [Abstract] [Full Text] [Related]

  • 15. The effect of berberine in vitro on tight junctions in human Caco-2 intestinal epithelial cells.
    Gu L, Li N, Li Q, Zhang Q, Wang C, Zhu W, Li J.
    Fitoterapia; 2009 Jun 01; 80(4):241-8. PubMed ID: 19243699
    [Abstract] [Full Text] [Related]

  • 16. Methylated N-(4-N,N-dimethylaminocinnamyl) chitosan enhances paracellular permeability across Caco-2 cells.
    Kowapradit J, Opanasopit P, Ngawhirunpat T, Rojanarata T, Ruktanonchai U, Sajomsang W.
    Drug Deliv; 2010 Jul 01; 17(5):301-12. PubMed ID: 20302396
    [Abstract] [Full Text] [Related]

  • 17. Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity via activation of guanylate cyclase-C in rat models.
    Boulete IM, Thadi A, Beaufrand C, Patwa V, Joshi A, Foss JA, Eddy EP, Eutamene H, Palejwala VA, Theodorou V, Shailubhai K.
    World J Gastroenterol; 2018 May 07; 24(17):1888-1900. PubMed ID: 29740204
    [Abstract] [Full Text] [Related]

  • 18. Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway.
    Yan H, Ajuwon KM.
    PLoS One; 2017 May 07; 12(6):e0179586. PubMed ID: 28654658
    [Abstract] [Full Text] [Related]

  • 19. Yogurt inhibits intestinal barrier dysfunction in Caco-2 cells by increasing tight junctions.
    Putt KK, Pei R, White HM, Bolling BW.
    Food Funct; 2017 Jan 25; 8(1):406-414. PubMed ID: 28091645
    [Abstract] [Full Text] [Related]

  • 20. Mast cell tryptase reduces junctional adhesion molecule-A (JAM-A) expression in intestinal epithelial cells: implications for the mechanisms of barrier dysfunction in irritable bowel syndrome.
    Wilcz-Villega EM, McClean S, O'Sullivan MA.
    Am J Gastroenterol; 2013 Jul 25; 108(7):1140-51. PubMed ID: 23588236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.